meta_pixel
Tapesearch Logo
Log in
The Intelligence from The Economist

Out for blood: the Theranos trial

The Intelligence from The Economist

The Economist

Global News, Daily News, News

4.53.7K Ratings

🗓️ 1 September 2021

⏱️ ? minutes

🧾️ Download transcript

Summary

Elizabeth Holmes founded a big blood-testing startup; her claims were founded on very little. As her trial begins we ask how the company got so far before it all crumbled. Research on primates is increasingly frowned upon in the West, leaving a strategic opportunity in places such as China. And lessons in a lost novel by French philosopher Simone de Beauvoir.

For full access to print, digital and audio editions of The Economist, subscribe here www.economist.com/intelligenceoffer


Hosted on Acast. See acast.com/privacy for more information.

Transcript

Click on a timestamp to play from that location

0:00.0

Hello and welcome to the Intelligence from the Economist.

0:06.8

I'm your host, Jason Palmer.

0:09.0

Every weekday we provide a fresh perspective on the events shaping your world.

0:17.6

A consistent push toward animal rights in the West has made research on primates increasingly

0:22.9

fraught, yet monkeys hold valuable secrets.

0:26.7

And as countries such as China and Japan press ahead, there will be scientific and strategic

0:31.9

consequences.

0:34.0

And we take a look at a new translation of a lost book by Simone de Beauvoir, a celebrated

0:39.1

feminist philosopher.

0:40.9

It reveals just how much a childhood friendship shaped both our personal and our professional

0:46.1

life.

0:55.9

First up though.

0:59.0

Elizabeth Holmes once graced the covers of magazines such as Forbes, gave talks at tech-savvy

1:04.4

conferences like Ted, mixed with the political and Silicon Valley elite.

1:09.6

Now she's about to stand trial, as soon as a sufficiently balanced jury can be found.

1:15.7

Theronos, the startup she founded in 2003, claimed to revolutionize the process of blood

1:21.2

testing and in so doing to alter healthcare itself.

1:24.9

We've created these little tiny tubes which are designed to replace the big traditional

1:32.3

tubes and instead allow for all the testing to be done from a tiny drop from a finger.

1:38.7

She raised hundreds of millions of dollars to manufacture those tiny tubes and struck

1:43.4

deals to ship them to pharmacies across America.

1:47.3

By 2015 the company was valued at nine billion dollars and Ms. Holmes was a media darling.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from The Economist, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Economist and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.